These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25978614)

  • 41. Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids.
    Iribarren C; Nordlander S; Sundin J; Isaksson S; Savolainen O; Törnblom H; Magnusson MK; Simrén M; Öhman L
    Neurogastroenterol Motil; 2022 Oct; 34(10):e14390. PubMed ID: 35485994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations.
    Vicario M; González-Castro AM; Martínez C; Lobo B; Pigrau M; Guilarte M; de Torres I; Mosquera JL; Fortea M; Sevillano-Aguilera C; Salvo-Romero E; Alonso C; Rodiño-Janeiro BK; Söderholm JD; Azpiroz F; Santos J
    Gut; 2015 Sep; 64(9):1379-88. PubMed ID: 25209656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
    Róka R; Rosztóczy A; Leveque M; Izbéki F; Nagy F; Molnár T; Lonovics J; Garcia-Villar R; Fioramonti J; Wittmann T; Bueno L
    Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A correlation study between diarrhea-predominant irritable bowel syndrome complicated functional dyspepsia patients of Gan-stagnation Pi-deficiency syndrome and gastrointestinal hormones].
    Zhao L; Song W; Zhu P; Zhang Y; Bu P
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1168-72. PubMed ID: 25509256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.
    Martínez C; Vicario M; Ramos L; Lobo B; Mosquera JL; Alonso C; Sánchez A; Guilarte M; Antolín M; de Torres I; González-Castro AM; Pigrau M; Saperas E; Azpiroz F; Santos J
    Am J Gastroenterol; 2012 May; 107(5):736-46. PubMed ID: 22415197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations.
    Pardo-Camacho C; Ganda Mall JP; Martínez C; Pigrau M; Expósito E; Albert-Bayo M; Melón-Ardanaz E; Nieto A; Rodiño-Janeiro B; Fortea M; Guagnozzi D; Rodriguez-Urrutia A; Torres I; Santos-Briones I; Azpiroz F; Lobo B; Alonso-Cotoner C; Santos J; González-Castro AM; Vicario M
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serotonin transporter gene (SLC6A4) polymorphism in patients with irritable bowel syndrome and healthy controls.
    Kumar S; Ranjan P; Mittal B; Ghoshal UC
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):31-8. PubMed ID: 22457857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Small intestine motility and gastrointestinal hormone levels in irritable bowel syndrome].
    Zhao JH; Dong L; Hao XQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1492-5. PubMed ID: 17959521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
    Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH
    Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.
    Gecse K; Róka R; Ferrier L; Leveque M; Eutamene H; Cartier C; Ait-Belgnaoui A; Rosztóczy A; Izbéki F; Fioramonti J; Wittmann T; Bueno L
    Gut; 2008 May; 57(5):591-9. PubMed ID: 18194983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome].
    Kong WM; Gong J; Dong L; Xu JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1345-7. PubMed ID: 17884774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of gut hormones with irritable bowel syndrome.
    Zhang H; Yan Y; Shi R; Lin Z; Wang M; Lin L
    Digestion; 2008; 78(2-3):72-6. PubMed ID: 18948690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
    Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lactase persistence/non-persistence genetic variants in irritable bowel syndrome in an endemic area for lactose malabsorption.
    Kumar S; Ranjan P; Mittal B; Singh R; Ghoshal UC
    J Gastroenterol Hepatol; 2012 Dec; 27(12):1825-30. PubMed ID: 22989008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators.
    Barbaro MR; Fuschi D; Cremon C; Carapelle M; Dino P; Marcellini MM; Dothel G; De Ponti F; Stanghellini V; Barbara G
    Neurogastroenterol Motil; 2018 Jun; ():e13388. PubMed ID: 29956419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS.
    Annaházi A; Ferrier L; Bézirard V; Lévêque M; Eutamène H; Ait-Belgnaoui A; Coëffier M; Ducrotté P; Róka R; Inczefi O; Gecse K; Rosztóczy A; Molnár T; Ringel-Kulka T; Ringel Y; Piche T; Theodorou V; Wittmann T; Bueno L
    Am J Gastroenterol; 2013 Aug; 108(8):1322-31. PubMed ID: 23711626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced Responses of Submucous Neurons from Irritable Bowel Syndrome Patients to a Cocktail Containing Histamine, Serotonin, TNFα, and Tryptase (IBS-Cocktail).
    Ostertag D; Buhner S; Michel K; Pehl C; Kurjak M; Götzberger M; Schulte-Frohlinde E; Frieling T; Enck P; Phillip J; Schemann M
    Front Neurosci; 2015; 9():465. PubMed ID: 26733780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.